136 related articles for article (PubMed ID: 26471694)
1. Exploratory Clinical Investigation of (4S)-4-(3-18F-Fluoropropyl)-L-Glutamate PET of Inflammatory and Infectious Lesions.
Chae SY; Choi CM; Shim TS; Park Y; Park CS; Lee HS; Lee SJ; Oh SJ; Kim SY; Baek S; Koglin N; Stephens AW; Dinkelborg LM; Moon DH
J Nucl Med; 2016 Jan; 57(1):67-9. PubMed ID: 26471694
[TBL] [Abstract][Full Text] [Related]
2. (4S)-4-(3-18F-fluoropropyl)-L-glutamate for imaging of xC transporter activity in hepatocellular carcinoma using PET: preclinical and exploratory clinical studies.
Baek S; Mueller A; Lim YS; Lee HC; Lee YJ; Gong G; Kim JS; Ryu JS; Oh SJ; Lee SJ; Bacher-Stier C; Fels L; Koglin N; Schatz CA; Dinkelborg LM; Moon DH
J Nucl Med; 2013 Jan; 54(1):117-23. PubMed ID: 23232273
[TBL] [Abstract][Full Text] [Related]
3. Exploratory clinical trial of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate for imaging xC- transporter using positron emission tomography in patients with non-small cell lung or breast cancer.
Baek S; Choi CM; Ahn SH; Lee JW; Gong G; Ryu JS; Oh SJ; Bacher-Stier C; Fels L; Koglin N; Hultsch C; Schatz CA; Dinkelborg LM; Mittra ES; Gambhir SS; Moon DH
Clin Cancer Res; 2012 Oct; 18(19):5427-37. PubMed ID: 22893629
[TBL] [Abstract][Full Text] [Related]
4. [
Hoehne A; James ML; Alam IS; Ronald JA; Schneider B; D'Souza A; Witney TH; Andrews LE; Cropper HC; Behera D; Gowrishankar G; Ding Z; Wyss-Coray T; Chin FT; Biswal S; Gambhir SS
J Neuroinflammation; 2018 Feb; 15(1):55. PubMed ID: 29471880
[TBL] [Abstract][Full Text] [Related]
5. Prospective comparison of (4S)-4-(3-
Cheng MF; Huang YY; Ho BY; Kuo TC; Hsin LW; Shiue CY; Kuo HC; Jeng YM; Yen RF; Tien YW
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):810-820. PubMed ID: 30635754
[TBL] [Abstract][Full Text] [Related]
6. Comparative Evaluation of [
Colovic M; Yang H; Southcott L; Merkens H; Colpo N; Bénard F; Schaffer P
J Nucl Med; 2023 Aug; 64(8):1314-1321. PubMed ID: 37116917
[TBL] [Abstract][Full Text] [Related]
7.
Wardak M; Sonni I; Fan AP; Minamimoto R; Jamali M; Hatami N; Zaharchuk G; Fischbein N; Nagpal S; Li G; Koglin N; Berndt M; Bullich S; Stephens AW; Dinkelborg LM; Abel T; Manning HC; Rosenberg J; Chin FT; Gambhir SS; Mittra ES
Radiology; 2022 Jun; 303(3):620-631. PubMed ID: 35191738
[TBL] [Abstract][Full Text] [Related]
8. Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.
Mittra ES; Koglin N; Mosci C; Kumar M; Hoehne A; Keu KV; Iagaru AH; Mueller A; Berndt M; Bullich S; Friebe M; Schmitt-Willich H; Gekeler V; Fels LM; Bacher-Stier C; Moon DH; Chin FT; Stephens AW; Dinkelborg LM; Gambhir SS
PLoS One; 2016; 11(2):e0148628. PubMed ID: 26890637
[TBL] [Abstract][Full Text] [Related]
9. Utility of [
Kavanaugh G; Williams J; Morris AS; Nickels ML; Walker R; Koglin N; Stephens AW; Washington MK; Geevarghese SK; Liu Q; Ayers D; Shyr Y; Manning HC
Mol Imaging Biol; 2016 Dec; 18(6):924-934. PubMed ID: 27677886
[TBL] [Abstract][Full Text] [Related]
10. Initial evaluation of (4S)-4-(3-[
Park SY; Mosci C; Kumar M; Wardak M; Koglin N; Bullich S; Mueller A; Berndt M; Stephens AW; Chin FT; Gambhir SS; Mittra ES
EJNMMI Res; 2020 Aug; 10(1):100. PubMed ID: 32857284
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Physiologic (18)F FSPG Uptake in Healthy Volunteers.
Mosci C; Kumar M; Smolarz K; Koglin N; Stephens AW; Schwaiger M; Gambhir SS; Mittra ES
Radiology; 2016 Jun; 279(3):898-905. PubMed ID: 26785040
[TBL] [Abstract][Full Text] [Related]
12. Clinical Evaluation of (4S)-4-(3-[
Park SY; Na SJ; Kumar M; Mosci C; Wardak M; Koglin N; Bullich S; Mueller A; Berndt M; Stephens AW; Cho YM; Ahn H; Chae SY; Kim HO; Moon DH; Gambhir SS; Mittra ES
Clin Cancer Res; 2020 Oct; 26(20):5380-5387. PubMed ID: 32694158
[TBL] [Abstract][Full Text] [Related]
13. PET Imaging of System x
Seo M; Kim Y; Ye BD; Park SH; Kim SY; Jung JH; Hwang SW; Chae SY; Lee DY; Lee SJ; Oh SJ; Kim J; Kim JY; Na SJ; Kim M; Kim SY; Koglin N; Stephens AW; Kweon MN; Moon DH
J Nucl Med; 2022 Oct; 63(10):1586-1591. PubMed ID: 35086893
[TBL] [Abstract][Full Text] [Related]
14. PET Imaging of L-Type Amino Acid Transporter (LAT1) and Cystine-Glutamate Antiporter (x
Krys D; Mattingly S; Glubrecht D; Wuest M; Wuest F
Mol Imaging Biol; 2020 Dec; 22(6):1562-1571. PubMed ID: 32789819
[TBL] [Abstract][Full Text] [Related]
15. Radiotracer stereochemistry affects substrate affinity and kinetics for improved imaging of system x
Greenwood HE; Edwards R; Koglin N; Berndt M; Baark F; Kim J; Firth G; Khalil E; Mueller A; Witney TH
Theranostics; 2022; 12(4):1921-1936. PubMed ID: 35198080
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and analysis of 4-(3-fluoropropyl)-glutamic acid stereoisomers to determine the stereochemical purity of (4S)-4-(3-[18F]fluoropropyl)-L-glutamic acid ([18F]FSPG) for clinical use.
Shih KT; Huang YY; Yang CY; Cheng MF; Tien YW; Shiue CY; Yen RF; Hsin LW
PLoS One; 2020; 15(12):e0243831. PubMed ID: 33315962
[TBL] [Abstract][Full Text] [Related]
17. Imaging the Tumor Antioxidant Response with [
Timmermand OV; Witney TH
Methods Mol Biol; 2024; 2729():233-249. PubMed ID: 38006500
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.
Okumura W; Iwasaki T; Toyama T; Iso T; Arai M; Oriuchi N; Endo K; Yokoyama T; Suzuki T; Kurabayashi M
J Nucl Med; 2004 Dec; 45(12):1989-98. PubMed ID: 15585472
[TBL] [Abstract][Full Text] [Related]
19. Specific PET imaging of xC- transporter activity using a ¹⁸F-labeled glutamate derivative reveals a dominant pathway in tumor metabolism.
Koglin N; Mueller A; Berndt M; Schmitt-Willich H; Toschi L; Stephens AW; Gekeler V; Friebe M; Dinkelborg LM
Clin Cancer Res; 2011 Sep; 17(18):6000-11. PubMed ID: 21750203
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]